122 web-programmer-developer-"U"-"Washington-University-in-St" PhD positions at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
Company description The Virology, Antiviral & Vaccine Research group at the Rega Institute, led by Prof. Johan Neyts, plays a leading role in the development of innovative antiviral strategies
-
individuals and patients with psychotic disorders” (funding period from 2025 to 2028) is German Research Foundation (DFG) funded. The applicant will contribute to the development, evaluation and application
-
), Universitätsmedizin Greifswald offers attractive benefits such as company pension schemes and employee discounts. Professional development opportunities: Regular training and development programs are offered to support
-
demonstrated experimental realizations and proven theoretical advantages. The project may involve several aspects, including mathematical theory, algorithm development, error correction, adaptation of GBS-based
-
, and state-of-the-art infrastructure. Our model empowers visionary leaders to accelerate drug development and harness AI-driven innovation to address unmet medical needs. Benefits of Working with Great
-
of teaching and research, the FSTM seeks to generate and disseminate knowledge and train new generations of responsible citizens in order to better understand, explain and advance society and environment we
-
contribute to the development of the Institute’s academic programs, mainly aimed at master's students, but also for bachelor's degrees, on-the-job training and MOOCs. The applicant will participate in
-
, regionally anchored top university as it focuses on the grand challenges of the 21st century. lt develops innovative solutions for the world's most pressing issues. In research and academic programs
-
translational cancer research. Omics based strategies, such as (epi-)genomics and transcriptomics, are opening unprecedented potential for developing novel precision oncology tools for improved diagnosis
-
divisions and research groups, the focus of our 1,400 scientists is to unravel the causes and mechanisms of cancer development and progression, and to develop novel strategies for the diagnosis, early